Adma Biologics (ADMA) Change in Acquisitions & Divestments (2016 - 2017)

Adma Biologics' (ADMA) quarterly Change in Acquisitions & Divestments came in at $245000.0 in Q2 2017, up 106.67% YoY from $118546.5 in Q2 2016, and down 95.24% on a QoQ basis from $5.1 million in Q1 2017.

Adma Biologics (ADMA) Change in Acquisitions & Divestments (2016 - 2017) Analysis & Trends

Adma Biologics (ADMA) has 2 years of Change in Acquisitions & Divestments data on file, last reported at $245000.0 in Q2 2017.

  • Quarterly Change in Acquisitions & Divestments rose 106.67% year-over-year to $245000.0 in Q2 2017, while the trailing twelve-month figure through Mar 2018 was $245000.0 (down 98.65% YoY) and the FY2017 annual result came in at $5.4 million, down 67.64% from the prior year.
  • Change in Acquisitions & Divestments eased to $245000.0 in Q2 2017, from $5.1 million in the prior quarter.
  • In the past five years, Change in Acquisitions & Divestments ranged from a high of $16.7 million in Q4 2016 to a low of -$3.7 million in Q2 2016.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Adma Biologics 2.13 Bn 2.00 Bn 86.28 Mn

Historic Data

Download Data
DateValue
Jun 30, 2017 245,000.00
Jun 30, 2017 245,000.00
Mar 31, 2017 5.15 Mn
Mar 31, 2017 5.15 Mn
Dec 31, 2016 16.66 Mn
Dec 31, 2016 16.66 Mn
Jun 30, 2016 -3.67 Mn
Jun 30, 2016 -3.67 Mn
Mar 31, 2016 3.67 Mn
Mar 31, 2016 3.67 Mn